Products in Development

TheraGlass® Products in Development

Pharming Group N.V. – Novel Device and Tissue Regenerative Products:

NovaThera Ltd has entered into a strategic alliance with Pharming Group N.V. to develop a suite of products based on the application of TheraGlass® in the delivery of Pharming’s proprietary recombinant Human (rH) proteins. The proteins covered in the alliance include rH C1-inhibitor, rH fibrinogen, rH collagen and rH lactoferrin.

The combination materials of TheraGlass® and Pharming’s rH proteins have applications ranging from soft tissue regeneration and bone repair through to device coatings, including cardiac stents (developed under the trade name TheraStent™).

Additional information on Pharming’s rH proteins can be found at www.pharming.com.

back